Hydrogel seton

• US 4,634,418 A
• Filed: 04/06/1984
• Issued: 01/06/1987
• Est. Priority Date: 04/06/1984
• Status: Expired due to Term

• Current Assignee: Perry S. Binder
• Original Assignee: Perry S. Binder
• Inventors: Binder, Perry S.
• Primary Examiner(s): Konopka, P. E.
• Application Number:
  US06/597,530
• Time in Patent Office: 1,005 Days
• Field of Search: 604/8, 604/93, 604/175, 604/264, 604/294, 3/1, 3/13, 623/4
• US Class Current: 604/8
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

A seton constructed of a hydrogel material is surgically implanted in the anterior chamber of the eye in order to alleviate intraocular pressure. Once implanted, the seton acts as a wick due to its porosity to reduce the intraocular pressure. The material from which the seton is constructed is a material which is biocompatible with the tissue of the eye and allows fluid within the eye to migrate about the seton without bacterial ingress to the eye, such as for example, a hydrogel material having a water content ranging from 30% to 79%.

Claims

1. A seton for reducing intraocular pressure comprising a body portion, said body portion being substantially triangular in shape and having a cross-section which varies from substantially elliptical to substantially oval, a neck portion extending from said body portion, a lip portion formed about said neck portion, said seton being constructed from a biocompatible porous hydrogel material and said seton further including a peripheral edge.

2. A seton as set forth in claim 1 wherein said lip portion is at the end of said neck portion farthest from said body portion.

3. A seton as set forth in claim 1 wherein said seton material is a hydrogel material having a water content ranging from 30% to 79%.

4. A seton as set forth in claim 3 wherein said seton peripheral edge is substantially rounded.

5. A seton for reducing intraocular pressure comprising a body portion, said body portion being substantially triangular in shape and having a cross section which varies from substantially elliptical to substantially oval, a neck portion extending from said body portion, a lip portion formed about said neck portion at the end of said neck portion farthest from said body portion, said seton being constructed from a biocompatible porous hydrogel material having a water content ranging from 30% to 79% and, said seton further including a peripheral edge which is substantially rounded.

6. A seton for relieving intraocular pressure comprising,

a body portion which is substantially triangular in shape and whose cross-section varies from substantially elliptical to substantially oval;

a neck portion extending from one corner of said body portion; and

,

a lip portion formed about said neck portion, said seton being constructed from a biocompatible porous hydrogel material.

7. A seton as set forth in claim 6 wherein said lip portion is at the end of said neck portion farthest from said body portion.

8. A seton as set forth in claim 6 wherein said biocompatible material is a hydrogel material having a water content ranging from 30% to 79%.

9. A seton for relieving intraocular pressure comprising,

a body portion and a lip portion, said body portion having a first end, said first end having a narrowed portion which is arranged for insertion into the anterior chamber of a human eye, said lip portion being formed on said narrowed portion of said first end of said body portion to inhibit the extrusion of said first end of said seton from the eye when said seton is implanted in the eye and said body portion being of a similar size or larger than said lip portion to prevent said seton from being drawn into the eye after said seton is implanted into the eye, said body portion and said lip portion being formed from a biocompatible porous hydrogel material.

10. A seton as set forth in claim 9 wherein said body portion is substantially triangular in shape.

11. A seton for reducing excessive intraocular pressure caused by glaucoma, comprising, a body portion, said body portion being substantially triangular in shape and having a cross section which varies from substantially elliptical to substantially oval, a neck portion extending from said body portion and a lip portion formed about said neck portion at the end of said neck portion farthest from said body portion, said seton being constructed from a biocompatible porous hydrogel material having a water content ranging from 30% to 79%.

12. A method for reducing intraocular pressure, the steps comprising,

creating a limbus-based conjunctiva and scleral flap by making an incision near the junction of the cornea and the sclera,

excising a portion of the cornea, Schalbe'"'"'s line and the trabecular meshwork by making incisions into the anterior chamber beneath said flap,

inserting a first end of a seton beneath said flap, said seton being constructed from a biocompatible porous hydrogel material and including a body portion and a lip portion, said lip portion being formed on said first end of said seton, said body portion having a peripheral edge,

suturing said flap about said seton such that said seton extends radially from the anterior chamber to the space beneath said flap and such that at least a portion of said seton extends from beneath said sutured flap, and

closing the conjunctiva about said flap and said seton.

13. The method as set forth by claim 12 wherein said seton is made from a hydrogel material having a water content ranging from 30% to 79%.

14. The method as set forth by claim 13 wherein said seton first end which is inserted in said incision through the sclera is larger than said incision so as to maintain the position of said seton when implanted and said body portion of said seton is substantially triangular in shape and has a cross-section which varies from substantially elliptical to substantially oval.

15. A method for reducing excessive intraocular pressure caused by glaucoma, the steps comprising, creating a limbus-based conjuctival and scleral flap by making an incision near the junction of the cornea and the sclera, excising a portion of the cornea, Schalbe'"'"'s Line and the trabecular meshwork by making an incision into the anterior chamber beneath said flap, inserting a first end of a seton beneath said flap, said seton being constructed from a biocompatible porous hydrogel material and including a body portion, a neck portion and a lip portion, said neck portion extending from said body portion, said lip portion being formed about said neck portion at the end of said neck portion farthest from said body portion, suturing said flap about said seton such that said seton extends radially from the anterior chamber of the eye into the space beneath said flap and such that at least a portion of said seton body is exposed beneath said sutured flap, and closing the conjunctiva about said flap and said seton.